These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 35143496)

  • 21. Evolutionary game analysis of air pollution co-investment in emission reductions by steel enterprises under carbon quota trading mechanism.
    Zhang C; Zhang X
    J Environ Manage; 2022 Sep; 317():115376. PubMed ID: 35642823
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Decisions of the Dual-Channel Supply Chain under Double Policy Considering Remanufacturing.
    Feng D; Ma L; Ding Y; Wu G; Zhang Y
    Int J Environ Res Public Health; 2019 Feb; 16(3):. PubMed ID: 30764542
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Research on services decision-making in closed-loop supply chain dominated by a logistics provider.
    Li W; Chen F; Deng L; Zhao Y
    Environ Sci Pollut Res Int; 2022 Aug; 29(37):55945-55956. PubMed ID: 35325381
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Who would rescue the dilemma of Chinese elderly care? An evolutionary game analysis and simulation research on the formalization of the domestic service industry with subsidy policy.
    Ren M; Chang X; Du S; Liu L
    Front Public Health; 2023; 11():1111208. PubMed ID: 37026124
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Co-evolutionary simulation study of multiple stakeholders in the take-out waste recycling industry chain.
    Long R; Yang J; Chen H; Li Q; Fang W; Wang L
    J Environ Manage; 2019 Feb; 231():701-713. PubMed ID: 30396143
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exploring the optimal reverse supply chain for e-waste treatment under Chinese government subsidy.
    Wang J; Li W; Mishima N; Adachi T
    Waste Manag; 2022 Jan; 137():128-138. PubMed ID: 34752946
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A carbon tax or a subsidy? Policy choice when a green firm competes with a high carbon emitter.
    Guo J; Huang R
    Environ Sci Pollut Res Int; 2022 Feb; 29(9):12845-12852. PubMed ID: 33442803
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Implementation of enterprises' green technology innovation under market-based environmental regulation: An evolutionary game approach.
    Li M; Gao X
    J Environ Manage; 2022 Apr; 308():114570. PubMed ID: 35124309
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of Government Subsidies on Production and Emissions Reduction Decisions under Carbon Tax Regulation and Consumer Low-Carbon Awareness.
    Wang W; Wang Y; Zhang X; Zhang D
    Int J Environ Res Public Health; 2021 Oct; 18(20):. PubMed ID: 34682705
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prefabrication decisions of the construction supply chain under government subsidies.
    Du Q; Hao T; Huang Y; Yan Y
    Environ Sci Pollut Res Int; 2022 Aug; 29(39):59127-59144. PubMed ID: 35380327
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vehicle Company's Decision-Making to Process Waste Batteries: A Game Research under the Influence of Different Government Subsidy Strategies.
    Zhan M; Chen Y
    Int J Environ Res Public Health; 2022 Oct; 19(21):. PubMed ID: 36360654
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analyzing the Effect of Government Subsidy on the Development of the Remanufacturing Industry.
    Zhou Q; Yuen KF
    Int J Environ Res Public Health; 2020 May; 17(10):. PubMed ID: 32438642
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Can the Behavioural Spillover Effect Affect the Environmental Regulations Strategy Choice of Local Governments?
    Deng Y; You D; Zhang Y
    Int J Environ Res Public Health; 2021 May; 18(9):. PubMed ID: 34067068
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence Mechanism on Supplier Emission Reduction Based on a Two-Level Supply Chain.
    Ma L; Zhang X; Du Y
    Int J Environ Res Public Health; 2021 Nov; 18(23):. PubMed ID: 34886165
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Public funding and private investment for R&D: a survey in China's pharmaceutical industry.
    Qiu L; Chen ZY; Lu DY; Hu H; Wang YT
    Health Res Policy Syst; 2014 Jun; 12():27. PubMed ID: 24925505
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Economic benefits of construction waste recycling enterprises under tax incentive policies.
    Liu J; Gong E; Wang X
    Environ Sci Pollut Res Int; 2022 Feb; 29(9):12574-12588. PubMed ID: 33856632
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Can the Profitability of Medical Enterprises Be Improved After Joining China's Centralized Drug Procurement? A Difference-in-Difference Design.
    Hua YF; Lu J; Bai B; Zhao HQ
    Front Public Health; 2021; 9():809453. PubMed ID: 35178375
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Does public subsidy promote sustainable innovation? The case of Chinese high-tech SMEs.
    Xiang D; Zhao T; Zhang N
    Environ Sci Pollut Res Int; 2021 Oct; 28(38):53493-53506. PubMed ID: 34036503
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stability of equilibrium production-price in a dynamic duopoly Cournot-Bertrand game with asymmetric information and cluster spillovers.
    Long J; Huang H
    Math Biosci Eng; 2022 Sep; 19(12):14056-14073. PubMed ID: 36654079
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Examining the link between price regulation and pharmaceutical R&D investment.
    Vernon JA
    Health Econ; 2005 Jan; 14(1):1-16. PubMed ID: 15386673
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.